Renée Galá
Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Renée Galá
Renée Galá is recorded as COO at Jazz Pharmaceuticals plc (JAZZ) since October 1, 2023. Jazz Pharmaceuticals plc reported in an 8-K filed September 12, 2023 that Renée Galá was appointed President and Chief Operating Officer, effective October 1, 2023. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
“On September 11, 2023, the Board appointed Renée Galá as the Company's President and Chief Operating Officer, effective as of October 1, 2023, to succeed Mr. Swisher as the Company's President and Chief Operating Officer.”
Affiliation history
-
Current
2023-10-01–present
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member